logo

NOVEL NUCLEIC ACID MOLECULES CUREVAC AG

If you want to confirm some technical details before you order,
just need to send a message or e-mail: [email protected].
Then our professional sales staff will contact you within 2 hours.

Novel sequence for improving expression of nucleic acid by Chromagenics B.V. – AU 20052616

Get details on patent AU2005261699 - Novel sequence for improving expression of nucleic acid by Chromagenics B.V. and more at IP in Australia IP Australia AU Patents charles-arthur-green christopher-john-tindall chromagenics-bv AU2005261699

CureVac and Arcturus Therapeutics Announce Broad Strategic Collaboration to Advance Next Generation of Lipid-Mediated mRNA Therapeutics - 04.01.20

CureVac AG, a leading clinical-stage biopharmaceutical company focused on the development of pioneering mRNA therapeutics, ... (RNAoptimizer ®) and Arcturus’s lipid-mediated nucleic acid delivery system (LUNAR ). The agreement focuses on developing ...

RNA world - Wikiped

The rRNA molecules are thought responsible for its enzymatic activity, as no amino acid molecules lie within 18 ... Threose nucleic acid has also been proposed as a starting point, as has glycol nucleic acid (), and like PNA, also lack experimental evidence ...

Vote for the Buzz of BIO at the 2019 CEO & Investor Conference – B

Arcturus' UNA oligomer chemistry can be incorporated into multiple types of nucleic acid medicines and is designed to improve the in vivo efficiency of mRNA-mediated protein replacement ...

Curevac Ag patents list (updated weekl

- Curevac Ag patent applications ... Electric Vehicle Patent Pack (PDFs) Research the latest Electric Vehicle inventions

Structural Biology of Protein & Nucleic Acid Complexes and Molecular Machines | IRB Barcelo

Mechanisms of Disease Structural Biology of Protein & Nucleic Acid Complexes and Molecular Machines Miquel Coll Group Leader Professor (IBMB-CSIC) [email protected] ...

Professor R Keith Fox | Biological Sciences | University of Southampt

Research interests My research concerns the sequence specific recognition of DNA by small molecules, oligonucleotides and proteins, and the formation of unusual DNA structures (triplexes and quadruplexes). Compounds that bind to DNA in a sequence specific ...

CureVac and Arcturus Therapeutics Announce Broad Strategic Collaboration to Advance Next Generation of Lipid-Mediated mRNA Therapeutics | More .

®) and Arcturus’s lipid-mediated nucleic acid delivery system (LUNAR ). ... About CureVac AG CureVac is a leading company in the field of messenger RNA (mRNA) technology with more than 17 years’ expertise in handling and optimizing ...

METHOD FOR ANALYSIS OF AN RNA MOLECULE - CureVac

The present invention relates to the field of RNA analysis. In particular, the invention concerns the use of a catalytic nucleic acid molecule for the analysis of an RNA molecule and/or of a population of RNA molecules. In one aspect, the invention concerns methods ...

Scientist Biotechnology - Drug Substance Process Development (f/m/d), Tübingen - CureVac AG - Biotechnologie - jobvect

Development, optimization and scale-up of GMP-compliant production steps for ribonucleic acid drug substances Method development for the analysis of nucleic acids, proteins and process-related impurities Support transfer of production steps and analytical ...

ARTIFICIAL NUCLEIC ACID MOLECULES - CureVac

The invention relates to an artificial nucleic acid molecule comprising at least one open reading frame and at least one 3′-untranslated region element (3′-UTR element) and/or at ...

Structural Biochemistry/Nucleic Acid/RNA/Messenger RNA (mRNA) - Wikibooks, open books for an open wor

In light of the hypothesis that these proteins might represent novel mRNA editing systems that could affect proteome diversity, we consider their structure, ...

Artificial Nucleic Acid Molecules (Curevac A

The invention relates to an artificial nucleic acid molecule comprising at least one open reading frame and at least one 3′-untranslated region element (3′-UTR) element comprising a nucleic acid sequence which is derived from the 3′-UTR of a ribosomal protein gene.

NOVEL MEMBERS OF THE CAPSAICIN/VANILLOID RECEPTOR FAMILY OF PROTEINS AND USES THEREOF - Patent - Europe P

The invention provides isolated nucleic acids molecules, designated hVR-1, hVR-2, and rVR-2 nucleic acid molecules, which encode novel members of the Capsaicin /Vanilloid receptor family. The invention also provides antisense nucleic acid molecules, recombinant ...

NUCLEIC ACID-FUNCTIONALIZED NANOMATERIA

NUCLEIC ACID-FUNCTIONALIZED NANOMATERIALS ISMAIL OCSOY*, , MUSERREF ARSLAN OCSOY†, , EMIR YASUN‡ and WEIHONG TAN Center for Research at the Bio/Nano Interface Department of Chemistry and Shands Cancer Center UF Genetics ...

Arcturus Therapeutics : CureVac and Arcturus Therapeutics Announce Broad Strategic Collaboration to Advance Next Generation of Lipid-Mediated mRNA .

January 4, 2018 TÜBINGEN, Germany & BOSTON & SAN DIEGO--CureVac AG, a leading clinical-stage biopharmaceutical company focused on the development of... ... Become ...

curevac.de: Publicatio

mRNA as novel technology for passive immunotherapy Schlake et al., Cellular and Molecular Life Sciences, June 2018. ... Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent Probst J et al ...

CureVac and Arcturus Therapeutics Announce Broad Strategic Collaboration to Advance Next Generation of Lipid-Mediated mRNA Therapeutics | More .

®) and Arcturus’s lipid-mediated nucleic acid delivery system (LUNAR ). ... About CureVac AG CureVac is a leading company in the field of messenger RNA (mRNA) technology with more than 17 years’ expertise in handling and optimizing ...

CureVac and Arcturus Therapeutics Announce Broad Strategic Collaboration to Advance Next Generation of Lipid-Mediated mRNA Therapeutics .

and Arcturus’s lipid-mediated nucleic acid delivery system (LUNAR ). The agreement focuses ... About CureVac AG CureVac is a leading company in the field of messenger ( ) technology with more than 17 years’ expertise in handling and optimizing this The ...

Novel application of Phi29 DNA polymerase: RNA detection and analysis in vitro and in situ by target RNA-primed R

Previously it was shown that Phi29 DNA polymerase has poor activity on RNA in double-stranded nucleic acid structures, but efficiently ... (10×), and RNA Loading Dye Solution (2×). Fetal bovine serum was purchased from Biochrom AG; creatinphosphate ...

Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 by Novartis AG – AU 20082443

Get details on patent AU2008244308 - Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 by Novartis AG and more at IP in Australia IP Australia AU Patents ng-steven novarbo-oy novartis-ag AU2008244308